Biomea Fusion (BMEA) Share-based Compensation (2021 - 2026)
Biomea Fusion's (BMEA) quarterly Share-based Compensation came in at $13.2 million in Q2 2026, down 14.29% year-over-year from $15.4 million in Q2 2025, and up 46.67% quarter-over-quarter from $9.0 million in Q1 2026.
Powered by 
Analysis
Biomea Fusion (BMEA) Share-based Compensation (2021 - 2026) Analysis & Trends
Biomea Fusion has disclosed Share-based Compensation across 6 years of filings, most recently posting $13.2 million for Q2 2026.
- In Q2 2026, Share-based Compensation fell 14.29% year-over-year to $13.2 million; the TTM figure through Jun 2026 stood at $13.2 million (down 14.29% YoY), while the FY2025 annual figure was $10.8 million, down 64.47% from the prior year.
- Share-based Compensation came in at $13.2 million for Q2 2026 at Biomea Fusion, up from $9.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $40.3 million in Q2 2024 to a low of $1.8 million in Q4 2025.
- Average Share-based Compensation over 5 years is $15.5 million, with a median of $11.9 million recorded in 2023.
- Year-over-year, Share-based Compensation surged 739.37% in 2022 and slumped 62.23% in 2025.
- Over 5 years, Share-based Compensation stood at $2.7 million in 2022, then decreased by 8.25% to $2.5 million in 2023, then jumped by 80.18% to $4.5 million in 2024, then tumbled by 59.06% to $1.8 million in 2025, then surged by 618.17% to $13.2 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $13.2 million in Q2 2026, $9.0 million in Q1 2026, and $1.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | -950.00 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 249.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 135.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 277.20 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 137.41 Mn |
| 10 | Biomea Fusion | 132.65 Mn | 132.65 Mn | - | 13.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.20 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 12.20 Mn |
| Jun 30, 2025 | 15.40 Mn |
| Mar 31, 2025 | 8.39 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 32.30 Mn |
| Jun 30, 2024 | 40.30 Mn |
| Mar 31, 2024 | 9.17 Mn |
| Dec 31, 2023 | 2.49 Mn |
| Sep 30, 2023 | 30.10 Mn |
| Jun 30, 2023 | 30.00 Mn |
| Mar 31, 2023 | 11.64 Mn |
| Dec 31, 2022 | 2.72 Mn |
| Sep 30, 2022 | 24.90 Mn |
| Jun 30, 2022 | 26.90 Mn |
| Mar 31, 2022 | 4.59 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 2.97 Mn |
API Access
Biomea Fusion Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BMEA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BMEA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BMEA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();